Ignite Creation Date:
2025-12-24 @ 3:50 PM
Ignite Modification Date:
2026-01-23 @ 8:11 AM
Study NCT ID:
NCT01707992
Status:
COMPLETED
Last Update Posted:
2021-11-09
First Post:
2012-09-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-02-20
Start Date Type:
ACTUAL
Primary Completion Date:
2015-04-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-07-04
Completion Date Type:
ACTUAL
First Submit Date:
2012-09-28
First Submit QC Date:
None
Study First Post Date:
2012-10-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-02-20
Results First Submit QC Date:
None
Results First Post Date:
2019-03-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-05-03
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-11-05
Last Update Post Date:
2021-11-09
Last Update Post Date Type:
ACTUAL